Table of Contents
ISRN Vascular Medicine
Volume 2013, Article ID 186759, 5 pages
http://dx.doi.org/10.1155/2013/186759
Clinical Study

Acute Effects of Two Angiotensin Receptor Blockers on Vascular Hemodynamics, Arterial Stiffness, and Oxidative Stress in Patients with Mild to Moderate Hypertension: An Open Label Parallel Group Study

1Narayana Medical College and Hospital, Chinthareddypalem, Nellore, Andhra Pradesh 524002, India
2Nizams Institute of Medical Sciences, Panjagutta, Hyderabad, Andhra Pradesh 500082, India

Received 1 November 2012; Accepted 9 December 2012

Academic Editors: A. Mugge and P. Schoenhagen

Copyright © 2013 Rama Mohan Pathapati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. W. Nichols and M. O’Rourke, McDonald’S Blood Flow in arteries. Theoretical, Experimental and Clinical principles, Arnold E, London, UK, 4th edition, 1998.
  2. S. Kinlay, M. A. Creager, M. Fukumoto et al., “Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo,” Hypertension, vol. 38, no. 5, pp. 1049–1053, 2001. View at Google Scholar · View at Scopus
  3. J. A. Panza, A. A. Quyyumi, J. E. Brush, and S. E. Epstein, “Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension,” New England Journal of Medicine, vol. 323, no. 1, pp. 22–27, 1990. View at Google Scholar · View at Scopus
  4. S. Laurent, “Arterial wall hypertrophy and stiffness in essential hypertensive patients,” Hypertension, vol. 26, no. 2, pp. 355–362, 1995. View at Google Scholar · View at Scopus
  5. T. W. Hansen, J. A. Staessen, C. Torp-Pedersen et al., “Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population,” Circulation, vol. 113, no. 5, pp. 664–670, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Touyz, “Reactive oxygen species in vascular biology: role in arterial hypertension,” Expert Review of Cardiovascular Therapy, vol. 1, no. 1, pp. 91–106, 2003. View at Google Scholar · View at Scopus
  7. I. B. Wilkinson, A. Qasem, C. M. McEniery, D. J. Webb, A. P. Avolio, and J. R. Cockcroft, “Nitric oxide regulates local arterial distensibility in vivo,” Circulation, vol. 105, no. 2, pp. 213–217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. U. R. Naidu, B. M. Reddy, S. Yashmaina, A. N. Patnaik, and P. U. Rani, “Validity and reproducibility of arterial pulse wave velocity measurement using new device with oscillometric technique: a pilot study,” BioMedical Engineering Online, vol. 4, article 49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Millasseau, F. G. Guigui, R. P. Kelly et al., “Noninvasive assessment of the digital volume pulse: comparison with the peripheral pressure pulse,” Hypertension, vol. 36, no. 6, pp. 952–956, 2000. View at Google Scholar · View at Scopus
  10. M. Dawes, P. J. Chowienczyk, and J. M. Ritter, “Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm,” Circulation, vol. 95, no. 9, pp. 2293–2297, 1997. View at Google Scholar · View at Scopus
  11. J. A. Beuge and S. D. Aust, “The thiobarbituric assay,” Methods in Enzymology, vol. 52, p. 306, 1978. View at Google Scholar
  12. A. Mahmud and J. Feely, “Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition,” American Journal of Hypertension, vol. 15, no. 4, pp. 321–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Uchida, Y. Nakamura, M. Kaihara et al., “Efficiency of Telmisartan on morning home blood pressure and arterial wall stiffness in patients with mild hypertension,” Hypertension Research, vol. 22, supplement 1, S148, p. 544, 2004. View at Google Scholar
  14. J. D. Mediavilla García, C. Fernández-Torres, F. Jaén Aguila, and J. Jiménez-Alonso, “Effect of olmesartan medoxomil on arterial stiffness in patients with essential hypertension,” Medicina Clínica, vol. 128, no. 19, pp. 726–729, 2007. View at Google Scholar
  15. H. Tomiyama, J. Yamada, Y. Koji, K. Shiina, M. Yoshida, and A. Yamashina, “Effect of Telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels,” American Journal of Hypertension, vol. 20, no. 12, pp. 1305–1311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Naya, T. Tsukamoto, K. Morita et al., “Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients,” Journal of the American College of Cardiology, vol. 50, no. 12, pp. 1144–1149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Keidar, J. Attias, J. Smith, J. L. Breslow, and T. Hayek, “The Angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice,” Biochemical and Biophysical Research Communications, vol. 236, no. 3, pp. 622–625, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Dandona, V. Kumar, A. Aljada et al., “Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-κB, in mononuclear cells of normal subjects: evidence of an antiinflammatory action,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 9, pp. 4496–4501, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Navalkar, S. Parthasarathy, N. Santanam, and B. V. Khan, “Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis,” Journal of the American College of Cardiology, vol. 37, no. 2, pp. 440–444, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. S. I. Yamagishi, T. Matsui, K. Nakamura et al., “Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species,” Ophthalmic Research, vol. 40, no. 1, pp. 10–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Saitoh, W. Hongwei, H. Ueno, M. Mizuta, and M. Nakazato, “Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic β-cells,” Diabetes and Metabolism, vol. 35, no. 5, pp. 392–397, 2009. View at Publisher · View at Google Scholar · View at Scopus